Literature DB >> 8543349

Clinical manifestations of bancroftian filariasis with special reference to lymphoedema grading.

S P Pani1, A Srividya.   

Abstract

We report on some aspects of progression of chronic disease and its association with acute manifestations with special reference to grades of lymphoedema in bancroftian filariasis. These analyses were based on the clinical history and clinical findings of 1300 individuals at the time of their first visit to the filariasis clinic at a centre in south India. The mean number of adenolymphangitis (ADL) attacks in one year was 4.9 +/- 1.7, 5.5 +/- 0.9 and 10.4 +/- 3.2 in patients with grade I, grade II and grade III lymphoedema respectively. The mean duration of oedema was 47.4 +/- 5.9 days, 6.2 +/- 0.5 and 8.6 +/- 0.9 yr in patients with grade I, grade II and grade III lymphoedema respectively. These findings suggest that the progression of lymphoedema from one grade to the next in bancroftian filariasis is associated with increased frequency of ADL attacks.

Entities:  

Mesh:

Year:  1995        PMID: 8543349

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  16 in total

1.  A longitudinal analysis of the effect of mass drug administration on acute inflammatory episodes and disease progression in lymphedema patients in Leogane, Haiti.

Authors:  Brittany A Eddy; Anna J Blackstock; John M Williamson; David G Addiss; Thomas G Streit; Valery M Beau de Rochars; Leanne M Fox
Journal:  Am J Trop Med Hyg       Date:  2013-11-11       Impact factor: 2.345

Review 2.  Immunopathogenesis of lymphatic filarial disease.

Authors:  Subash Babu; Thomas B Nutman
Journal:  Semin Immunopathol       Date:  2012-10-03       Impact factor: 9.623

Review 3.  Insights into the pathogenesis of disease in human lymphatic filariasis.

Authors:  Thomas B Nutman
Journal:  Lymphat Res Biol       Date:  2013-09       Impact factor: 2.589

4.  Feasibility and effectiveness of basic lymphedema management in Leogane, Haiti, an area endemic for bancroftian filariasis.

Authors:  David G Addiss; Jacky Louis-Charles; Jacquelin Roberts; Frederic Leconte; Joyanna M Wendt; Marie Denise Milord; Patrick J Lammie; Gerusa Dreyer
Journal:  PLoS Negl Trop Dis       Date:  2010-04-20

5.  Histopathologic improvement with lymphedema management, Léogâne, Haiti.

Authors:  Susan F Wilson; Jeannette Guarner; Alix L Valme; Jacky Louis-Charles; Tara L Jones; David G Addiss
Journal:  Emerg Infect Dis       Date:  2004-11       Impact factor: 6.883

6.  Issues in delivering morbidity management for lymphatic filariasis elimination: a study in Pondicherry, South India.

Authors:  A Krishna Kumari; Yuvaraj J; L K Das
Journal:  ScientificWorldJournal       Date:  2012-04-30

7.  Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.

Authors:  David G Addiss; Molly A Brady
Journal:  Filaria J       Date:  2007-02-15

8.  Lymphoedema: Pathophysiology and management in resource-poor settings - relevance for lymphatic filariasis control programmes.

Authors:  Babar Vaqas; Terence J Ryan
Journal:  Filaria J       Date:  2003-03-12

9.  An integrated in vitro imaging platform for characterizing filarial parasite behavior within a multicellular microenvironment.

Authors:  Timothy Kassis; Henry M Skelton; Iris M Lu; Andrew R Moorhead; J Brandon Dixon
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

10.  Molecular evidence on the occurrence of co-infection with Pichia guilliermondii and Wuchereria bancrofti in two filarial endemic districts of India.

Authors:  Suprabhat Mukherjee; Niladri Mukherjee; Prasanta Saini; Prajna Gayen; Priya Roy; Santi P Sinha Babu
Journal:  Infect Dis Poverty       Date:  2014-04-07       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.